2011 A Record Year for Accumetrics and Platelet Reactivity Testing
Company Poised to Capitalize on Four Published Guideline Recommendations, New Clinical Data, CE-Marked Prognostic Claim and Generic Clopidogrel in 2012
2011 A Record Year for Accumetrics and Platelet Reactivity Testing
Company Poised to Capitalize on Four Published Guideline Recommendations, New Clinical Data, CE-Marked Prognostic Claim and Generic Clopidogrel in 2012